tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Positive Outlook for Ligand Pharma: FDA Approval and Strategic Expansion Drive Growth Potential
PremiumRatingsPositive Outlook for Ligand Pharma: FDA Approval and Strategic Expansion Drive Growth Potential
1M ago
Ligand price target raised to $206 from $157 at H.C. Wainwright
Premium
The Fly
Ligand price target raised to $206 from $157 at H.C. Wainwright
1M ago
Ligand Pharma Completes $460M Convertible Notes Offering
Premium
Company Announcements
Ligand Pharma Completes $460M Convertible Notes Offering
2M ago
Ligand price target raised to $185 from $155 at RBC Capital
PremiumThe FlyLigand price target raised to $185 from $155 at RBC Capital
2M ago
Ligand Pharmaceuticals Reports Strong Q2 2025 Results
Premium
Company Announcements
Ligand Pharmaceuticals Reports Strong Q2 2025 Results
2M ago
Positive Outlook on Ligand Pharma: Strong Financial Performance and Strategic Positioning Drive Buy Rating
Premium
Ratings
Positive Outlook on Ligand Pharma: Strong Financial Performance and Strategic Positioning Drive Buy Rating
2M ago
Ligand price target raised to $162 from $145 at Oppenheimer
PremiumThe FlyLigand price target raised to $162 from $145 at Oppenheimer
2M ago
Ligand management to meet with Oppenheimer
Premium
The Fly
Ligand management to meet with Oppenheimer
2M ago
Ligand partner Pelthos launches ZELSUVMI topical gel
Premium
The Fly
Ligand partner Pelthos launches ZELSUVMI topical gel
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100